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161 E3 ubiquitin ligases: A potential role in regulating the
inﬂammatory phenotype of cystic ﬁbrosis?
S. Canato1, M. Telhada1, M.D. Amaral1, L. Clarke1. 1Center for Biodiversity,
Functional & Integrative Genomics (BioFIG), Membrane Protein Disorders Unit,
Lisbon, Portugal
Cystic Fibrosis (CF) is characterized by an aggressive inﬂammatory response.
One important marker of CF lung disease, the pleiotropic cytokine TGF-beta,
is negatively regulated by E3-ubiquitin ligases, which have been found to be
dysregulated in previous studies of F508del-CFTR-related gene expression.
To understand the role of E3-ubiquitin ligases in CF, we studied the effects of:
1. F508del mutation and
2. exposure to TGF-beta and TNF-alpha cytokines on mRNA and protein expres-
sion of the E3-ubiquitin ligases SMURF1, SMURF2 and NEDD4L in polarized
CF bronchial epithelial cell models.
Using real-time quantitative PCR, we demonstrated that the F508del mutation is
not sufﬁcient to induce signiﬁcant differential mRNA expression of E3-ubiquitin
ligases. However, the F508del-CFTR genotype altered the responsiveness of E3-
ubiquitin ligases to both inﬂammatory cytokines. Our results showed that both
TGF-beta and TNF-alpha increased the expression of SMURF2 mRNA in F508del-
CFTR CFBE cells, suggesting an up-regulation of this E3-ubiquitin ligase under
inﬂammatory status. In addition, this increased expression was consistent with an
observed decrease in SMAD2 and SMAD3 mRNA expression. These results suggest
that increased expression of E3-ubiquitin ligases in CF under inﬂammation could
be partly responsible for the increased pro-inﬂammatory mediators that characterize
CF disease, via an inhibition of the Smad-dependent anti-inﬂammatory effects of
TGF-beta. Our preliminary data enlighten the potential implications of differential
expression of enzymes involved in ubiquitination on modulation of CF inﬂammatory
responses.
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162 Serum amyloid A as a useful serum marker of lung inﬂammation in
cystic ﬁbrosis
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L. Minicucci1. 1IRCCS G. Gaslini, Cystic Fibrosis Centre, Genoa, Italy; 2IRCCS G.
Gaslini, Scientiﬁc Direction, Epidemiology Service, Genoa, Italy
Anti-inﬂammatories are an attractive therapeutic target in CF with a proven ability to
slow down lung disease. Up to now, a serum biomarker able to deﬁne inﬂammation
baseline state and to determine therapy efﬁcacy, is not available. Serum amyloid
A (SAA) is an acute-phase protein, whose serum concentration represents a useful
inﬂammatory marker, particularly in rheumatic diseases. We decided to compare SAA
values with CRP values, that are strongly related with acute infective exacerbations, and
clinical parameters, useful to deﬁne baseline lung condition. We tested SAA (normal
value: <6.4mg/l) in 147 serum samples from 107 CF patients, followed by Genoa
CF Centre in 2012. We divided SAA results in 5 groups and we collected for each
patient age, average annual FEV1%, P. aeruginosa colonization and CRP value at the
time of every SAA collection (Table 1). P.a. positivity is highly related with SAA
values (median value in P.a. positive 50.1mg/l, median value in P.a. negative 5.5mg/l:
p< 0.0001). No correlation was observed between SAA values and age (rs = 0.29). A
strong correlation was observed between SAA and CRP values (n = 147; rs = 0.77) and
a moderate inverse correlation emerged between SAA and FEV1% (n = 133; rs = −0.58).
In conclusion SAA, in CF, can be useful to deﬁne, as CRP, acute inﬂammatory events,
but also to characterize lung inﬂammatory baseline condition.
Table 1.
Samples
(n)
Mean
SAA
(mg/l)
Mean
CRP
(mg/dl)
%CRP
negative
(<0.46mg/dl)
Age
(yrs)
%FEV1
(Annual
average)
%P. aeruginosa
positive
Group 1
(SAA <6.4mg/l)
26 2.0 0.17 100.0% 20.29 88.0% 25.0%
Group 2
(SAA 6.4−64mg/l)
72 27.5 0.56 64.3% 23.68 64.3% 73.2%
Group 3
(SAA 64.1−128mg/l)
21 86.2 0.99 47.6% 28.50 47.5% 100.0%
Group 4
(SAA 128.1−256mg/l)
15 176.4 1.95 6.6% 27.21 50.5% 92.9%
Group 5
(SAA >256mg/l)
13 433.0 4.13 0.0% 27.00 36.6% 100.0%
163 A role for the WFDC protein, WAP2, in the regulation of
inﬂammatory response in the lung
A. Glasgow1, S. Weldon1, A. Scott1, D. McLean1, N. Camper1, F. Lundy1,
P. McNally2, J.S. Elborn1, C. Taggart1. 1Queen’s University Belfast, Centre for
Infection and Immunity, Belfast, United Kingdom; 2Our Lady’s Children’s Hospital
Crumlin, Dublin, Ireland
Objectives: SLPI and elaﬁn are members of the WAP Four-Disulphide-Core
(WFDC) family of proteins and have multiple contributions to innate immunity
including inhibition of neutrophil serine proteases and inhibition of the inﬂamma-
tory response to LPS. The aims of this research were to explore potential activities
of WAP2, a previously uncharacterised WFDC protein expressed in the lung.
Methods: Recombinant expression and puriﬁcation of WAP2 were optimised in
E. coli. Cathepsin G and elastase activity assays were used to test anti-protease
activity of rWAP2. To investigate anti-inﬂammatory activity, THP-1 monocytic cells
were given LPS alone or rWAP2 in combination with LPS. Cytokine levels in cell-
free supernatants were subsequently analysed by ELISA. To test if WAP2 could
become cross-linked to extracellular matrix proteins, rWAP2 was incubated with
ﬁbronectin +/− transglutaminase, and then assessed by SDS-PAGE and Western
blotting. BALF samples from CF patients were examined for the presence of
endogenous WAP2 via Western blot.
Conclusion: Recombinant WAP2 inhibited cathepsin G but not elastase activity.
Monocytic cells pre-treated with rWAP2 before LPS stimulation showed signiﬁ-
cantly lower levels of IL-8 and MCP-1 production compared to cells given LPS
alone. Recombinant WAP2 was conjugated to ﬁbronectin in a transglutaminase-
mediated reaction and retained anti-protease activity. WAP2 was detected at variable
levels in BALF from CF patients. Together these results suggest a role for this
lesser known WFDC protein in the regulation of inﬂammation; therefore further
investigation is warranted to determine its merit as a possible therapeutic agent.
164 Neutrophil elastase-mediated increase in airway temperature during
inﬂammation
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Objectives: P. aeruginosa is the dominant pathogen in chronic lung infections in CF.
The reason(s) for this selection is unclear.
Methods: We determined airway and sputum temperatures in CF patients and healthy
controls. Additionally, we measured the enthalpy of the binding reaction between
puriﬁed human neutrophil elastase (NE) and its endogenous inhibitor a1-PI and pouch
temperatures in wild type and isogenic NE−/− mice. We cultured bacterial pathogens at
30ºC, 38ºC and 39ºC for 96 h anaerobically, and measured their density. We compared
the transcriptome of P. aeruginosa after anaerobic growth at 30ºC and 38ºC and
sequenced the microbiota in 8 paired early and late CF sputum specimens.
Results: PLET temperatures in 56 CF patients were inversely correlated to lung
function. Within mucus plugs 37.98±0.80ºC was measured while airway lumenal
temperatures were 36.62±0.91ºC. NE bound to a1-PI in an exothermic reaction with a
binding enthalpy of −18.5±1.3 kcal/mol. Temperatures in pouch airspaces of infected
WT mice were signiﬁcantly higher compared to controls. After 96 h at 38ºC, the
densities of many bacterial species were signiﬁcantly lower (or remained constant) vs.
30ºC while only P. aeruginosa grew at 38ºC or higher. We identiﬁed 858 differentially
expressed genes at 38ºC vs 30ºC including virulence genes, quorum sensing system
genes and thermotolerance genes. The mean P. aeruginosa relative abundance was
0.191 in early sputum samples and 0.592 in late samples.
Conclusion: NE mediates a temperature increase in mucus plugs of CF patients which
favours the selection of P. aeruginosa.
